Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
European Urology Oncology|September 29, 2022
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized TrialYasemin Melisa Saner, Manuel Wiesenfarth, Vivienn Weru, et al.
European Urology Open Science|April 28, 2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy ProceduresTimo F W Soeterik, Xiaobo Wu, Roderick C N Van den Bergh, et al.
European Urology Focus|March 18, 2019
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active SurveillanceSvenja Dieffenbacher, Joanne Nyarangi-Dix, Francesco Giganti, et al.
European Urology Open Science|June 26, 2023
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensChristopher Darr, Pedro Fragoso Costa, Theresa Kahl, et al.
Central European Journal of Urology|November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional studyFabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
European Urology|April 13, 2017
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary BiopsiesJan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, et al.
European Urology|January 27, 2016
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenJan P Radtke, Constantin Schwab, Maya B Wolf, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept StudyClaudia Kesch, Maria Vinsensia, Jan P Radtke, et al.
Minerva Urology and Nephrology|November 28, 2024
Conversions in robot-assisted partial nephrectomy: a multicentric analysis of 2549 casesOlga Katzendorn, Frank Schiefelbein, Georg Schoen, et al.
Pageof 11